Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Idelalisib

EU orphan designation number: EU/3/13/1160
Active ingredient: Idelalisib
Indication: Treatment of lymphoplasmacytic lymphoma
Sponsor: Gilead Sciences International Ltd
Flowers Building, Granta Park, Abington, Cambridge CB21 6GT United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/08/2013 Centralised Orphan - Designation EMA/OD/055/13 (2013)4734 of 17/07/2013
21/10/2013 Centralised Orphan - Removal of orphan designation from Community Register